A detailed history of Sphera Funds Management Ltd. transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 1,814,213 shares of PMN stock, worth $2.09 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
1,814,213
Previous 1,834,047 1.08%
Holding current value
$2.09 Million
Previous $3.5 Million 22.32%
% of portfolio
0.4%
Previous 0.55%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.5 - $2.49 $29,751 - $49,386
-19,834 Reduced 1.08%
1,814,213 $2.72 Million
Q1 2024

May 15, 2024

BUY
$1.28 - $2.81 $6 - $14
5 Added 0.0%
1,834,047 $3.5 Million
Q3 2023

Nov 14, 2023

BUY
$1.52 - $6.19 $2.79 Million - $11.4 Million
1,834,042 New
1,834,042 $3.63 Million

Others Institutions Holding PMN

About ProMIS Neurosciences Inc.


  • Ticker PMN
  • Exchange OTC
  • Description
  • ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...
More about PMN
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.